Budesonide after stretching for child esophageal narrowing
Part of Digestive system clinical trials.
This study tests whether giving budesonide (a steroid medicine) after a stretching procedure (endoscopic dilatation) for a narrowing at the site of a repaired congenital esophageal blockage can help keep the esophagus open and improve swallowing in children. It is for children under 12 who have not had prior stretching for this same narrowing and who meet other specific health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 12 years old and have had surgery to fix a congenital esophageal blockage (esophageal atresia), with a narrowing at the surgery site.
- Your child must have some trouble swallowing (dysphagia score of 1 or more).
- Your child must not have had any previous dilatation (stretching) procedures for this narrowing.
- Your child must not have any other narrowing in the esophagus besides the one at the surgery site.
- Your child must not have significant neurological problems that would affect their ability to eat by mouth.
- Your child must not have had a complicated surgical course (like re-operation, re-fistula, or leak) or other specified conditions like a vascular anomaly or eosinophilic esophagitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications, tranilast and steroids, to see which is better at preventing the esophagus from narrowing after a procedure to remove early-stage cancer or precancerous growths. If you are having this procedure, you may be eligible to participate.
This study tests whether a paclitaxel-coated balloon can keep the esophagus (food pipe) open longer in people with a stubborn benign narrowing. It aims to improve swallowing by reducing how often the narrowing needs repeat stretching.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This study looks at whether budesonide, a medicine that reduces inflammation, helps people with a rare skin condition called epidermolysis bullosa who have trouble swallowing. It reviews past treatment results to see if it worked.
This trial tests a budesonide liquid that targets inflammation in the esophagus, stomach, and duodenum (upper digestive tract) in children with Crohn's disease. It aims to see if this treatment can reduce inflammation in those areas without strong side effects.
This study compares two balloon inflation times (30 seconds vs 60 seconds) to see which works better for treating narrow spots in the esophagus that form after esophageal atresia repair.
Hear when a new Esophageal Stricture trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.